In This Article:
In November 2024, global markets are navigating a landscape marked by policy uncertainties from the incoming Trump administration and fluctuating interest rate expectations, which have influenced sector performances and investor sentiment. Amidst these dynamics, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between management and shareholders.
Top 10 Growth Companies With High Insider Ownership
Name | Insider Ownership | Earnings Growth |
People & Technology (KOSDAQ:A137400) | 16.4% | 37.3% |
Archean Chemical Industries (NSEI:ACI) | 22.9% | 43% |
Kirloskar Pneumatic (BSE:505283) | 30.3% | 26.3% |
Laopu Gold (SEHK:6181) | 36.4% | 33.9% |
Seojin SystemLtd (KOSDAQ:A178320) | 31.1% | 52.4% |
Medley (TSE:4480) | 34% | 31.5% |
Findi (ASX:FND) | 34.8% | 64.8% |
Plenti Group (ASX:PLT) | 12.8% | 107.6% |
Brightstar Resources (ASX:BTR) | 16.2% | 84.6% |
UTI (KOSDAQ:A179900) | 33.1% | 134.6% |
Underneath we present a selection of stocks filtered out by our screen.
HYBE
Simply Wall St Growth Rating: ★★★★☆☆
Overview: HYBE Co., Ltd. operates in music production, publishing, and artist development and management with a market cap of ₩8.81 trillion.
Operations: The company's revenue is primarily derived from three segments: Label (₩1.28 trillion), Platform (₩361.12 billion), and Solution (₩1.24 trillion).
Insider Ownership: 32.5%
Revenue Growth Forecast: 14.5% p.a.
HYBE's earnings are forecast to grow significantly at 38.1% annually, outpacing the Korean market. Despite one-off items impacting recent results, its revenue is expected to rise by 14.5% per year, surpassing the market average. Recent strategic moves include a KRW 400 billion private placement of convertible bonds and a completed share buyback program aimed at stabilizing stock prices. Analysts agree on a potential price increase of 21.4%, reflecting positive sentiment towards future growth prospects.
-
Navigate through the intricacies of HYBE with our comprehensive analyst estimates report here.
-
Our expertly prepared valuation report HYBE implies its share price may be too high.
Surgical Science Sweden
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training globally, with a market cap of approximately SEK7.27 billion.
Operations: Surgical Science Sweden AB generates revenue from developing and marketing virtual reality simulators for medical training across Europe, the Americas, Asia, and other international markets.